CLGN Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 30, 2026
Report Source: 2025 Annual Report
Collplant Biotechnologies Ltd. Stock Analysis CLGN
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 39 full-time employees. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Read More Collplant Biotechnologies Ltd (CLGN) Chart
Key Statistics of Collplant Biotechnologies Ltd (CLGN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.43Volume
28.61KP/E Ratio (TTM)
-52 Week Range
Market Cap
5.77MAvg. Volume
117.27KDividend Yield
-Financial Metrics & Statements of Collplant Biotechnologies Ltd (CLGN)
FAQ's for Collplant Biotechnologies Ltd (CLGN)
- According to Musaffa’s Shariah screening methodology, Collplant Biotechnologies Ltd (CLGN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.